Salahuddin Mirza
3PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 18, 2022
Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy.Laura Schäkel, Salahuddin Mirza, Riekje Winzer
|Aug 06, 2021
Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.Sang-Yong Lee, Vigneshwaran Namasivayam, Nader M Boshta
|Mar 03, 2021
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.Julian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar
Pageof 1
Frequent Collaborators
3 joint publications
Christa E Müller
2 joint publications
Laura Schäkel
2 joint publications
Vittoria Lopez
2 joint publications
Vigneshwaran Namasivayam
1 joint publications
Julian Breidenbach
1 joint publications
Carina Lemke
1 joint publications
Thanigaimalai Pillaiyar
1 joint publications
Ghazl Al Hamwi
1 joint publications
Nina Geiger
1 joint publications
Anke C Schiedel
